von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3.
Casari C, Berrou E, Lebret M, Adam F, Kauskot A, Bobe R, Desconclois C, Fressinaud E, Christophe OD, Lenting PJ, Rosa JP, Denis CV, Bryckaert M.
Casari C, et al. Among authors: denis cv.
J Clin Invest. 2013 Dec;123(12):5071-81. doi: 10.1172/JCI69458. Epub 2013 Nov 25.
J Clin Invest. 2013.
PMID: 24270421
Free PMC article.